THE EFFICACY OF SWITCHING FROM OTHER BASAL INSULIN TO INSULIN DEGLUDEC AMONG PATIENTS WITH TYPE 1 AND TYPE 2 DIABETES ON INTENSIVE INSULIN THERAPY

被引：0
|
作者：
Kakizaki, Y. [1 ]
Sasaki, J. [1 ]
Sakakura, K. [2 ]
Tamaru, S. [1 ]
Shikuma, J. [1 ]
Ito, R. [1 ]
Miwa, T. [1 ]
Odawara, M. [1 ]
机构：
[1] Tokyo Med Univ, Dept Diabet Endcrinol & Metab, Tokyo 1608402, Japan
[2] Tokyo Med Univ, Dept Pharm, Tokyo 1608402, Japan
来源：
DIABETES RESEARCH AND CLINICAL PRACTICE | 2014年 / 106卷
关键词：
D O I：
10.1016/S0168-8227(14)70552-2
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PO258
引用
收藏
页码：S181 / S181
页数：1
相关论文
共 50 条
  • [21] A Randomized Crossover Study of the Efficacy and Safety of Switching from Insulin Glargine to Insulin Degludec in Children with Type 1 Diabetes
    Urakami, Tatsuhiko
    Mine, Yusuke
    Kuwabara, Remi
    Aoki, Masako
    Okuno, Misako
    Suzuki, Junichi
    DIABETES, 2015, 64 : A366 - A366
  • [22] A randomized crossover study of the efficacy and safety of switching from insulin glargine to insulin degludec in children with type 1 diabetes
    Urakami, Tatsuhiko
    Mine, Yusuke
    Aoki, Masako
    Okuno, Misako
    Suzuki, Junichi
    ENDOCRINE JOURNAL, 2017, 64 (02) : 133 - 140
  • [23] Efficacy of combining insulin glulisine with basal insulin glargine in patients with type I and type 2 diabetes previously on premix insulin therapy
    Schreiber, S.
    Ferlinz, K.
    Donaubauer, B.
    DIABETOLOGIA, 2007, 50 : S410 - S411
  • [24] Real-World Assessment of Clinical Effectiveness when Switching to Insulin Degludec from Another Basal Insulin among Type 2 Diabetes Patients in the US
    Tibaldi, Joseph M.
    Hansen, Brian B.
    Wolden, Michael L.
    Moralea, Maria E.
    Yue, Yinan
    Weatherall, James
    Rodbard, Helena W.
    DIABETES, 2017, 66 : A261 - A261
  • [25] SAFETY AND EFFICACY OF INSULIN GLARGINE/LIXISENATIDE AND INSULIN DEGLUDEC/INSULIN ASPART IN TYPE 2 DIABETES PATIENTS NOT CONTROLLED ON BASAL INSULIN: A NETWORK META-ANALYSIS
    Jammah, A.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2020, 22 : A185 - A186
  • [26] Effect of switching basal insulin regimen to degludec on quality of life in Japanese patients with type 1 and type 2 diabetes mellitus
    Okada M.
    Okada M.
    Nishigami J.
    Yamaaki N.
    Furukawa K.
    Ohyama K.
    Shimada T.
    Sai Y.
    Journal of Pharmaceutical Health Care and Sciences, 1 (1)
  • [27] Intensive insulin therapy in type 1 and type 2 diabetes
    Dean, J
    Sharp, P
    HOSPITAL MEDICINE, 2004, 65 (05): : 288 - 292
  • [28] Insulin degludec/insulin aspart combination for the treatment of type 1 and type 2 diabetes
    Dardano, Angela
    Bianchi, Cristina
    Del Prato, Stefano
    Miccoli, Roberto
    VASCULAR HEALTH AND RISK MANAGEMENT, 2014, 10 : 465 - 475
  • [29] Switching Patients with Type 1 Diabetes to Insulin Degludec from Other Basal Insulins: Real-World Data of Effectiveness and Safety
    Paola Ponzani
    Cesare Berra
    Alessandra Di Lelio
    Paola Del Sindaco
    Chiara Di Loreto
    Francesco Reggiani
    Giuseppe Lucisano
    Maria Chiara Rossi
    Diabetes Therapy, 2020, 11 : 97 - 105
  • [30] Switching Patients with Type 1 Diabetes to Insulin Degludec from Other Basal Insulins: Real-World Data of Effectiveness and Safety
    Ponzani, Paola
    Berra, Cesare
    Di Lelio, Alessandra
    Del Sindaco, Paola
    Di Loreto, Chiara
    Reggiani, Francesco
    Lucisano, Giuseppe
    Rossi, Maria Chiara
    DIABETES THERAPY, 2020, 11 (01) : 97 - 105
12345